Barbell Medicine Podcast · Barbell Medicine

Episode #389: Your Liver Enzymes Are Elevated — But It Might Not Be Your Liver

·1 hr 2 min·4 clips
56% of physicians missed exercise-induced muscle damage in a young man with elevated liver-associated enzymes.
The episode opens with a familiar medical trap. A young, active, asymptomatic man gets routine labs, and the results point toward trouble. The hosts quickly ask whether the liver is really the organ in distress. They frame the case as a reminder that transaminases, more accurately called liver-associated enzymes, are not the same thing as a diagnosis. The discussion then turns to a survey showing how often physicians miss exercise-induced muscle damage in this setting. That statistic becomes the main problem. It is not just a lab puzzle. It is also a problem in how clinicians are taught to read abnormal numbers. The hosts also spend time on the emotional side of the encounter. The clinician sees the labs and the patient sees the panic. That panic can trigger expensive imaging, viral screening, and sometimes biopsy before the basic context has been weighed carefully. The episode keeps pushing on that reflex. It asks what happens when the thing making someone healthier is also making the labs look abnormal. That question drives the whole conversation. From there, the differential gets built piece by piece. Viral hepatitis is considered and then moved past in the case as discussed. Fatty liver disease stays in view, even if it is less likely in a lean, active patient. Drug-induced liver injury remains on the table too. The hosts note how gym-focused patients may not mention everything they take, which matters more than people usually admit. Supplements can complicate the picture. So can anabolic agents and other products that are easy to minimize in an intake history. The episode spends real time on the supplement issue. Synephrine and caffeine come up as a possible contributor to severe rhabdomyolysis. Ephedra is mentioned as a banned example with a known association. Oral anabolic androgenic steroids are described as potentially hepatotoxic. Herbal products are not treated as harmless by default. The point is not to scare people. The point is that the differential should stay open until the history is actually trustworthy. The hosts keep returning to exercise because it is the missing explanation many clinicians fail to write down. That omission matters. If the patient worked out before the blood draw, that detail can change the whole interpretation. The episode does not claim every elevation is benign. It argues that the habit of assuming liver disease is too narrow. A creatine kinase test would have helped move the case in the right direction. So would a more disciplined history. The tone stays measured throughout. There is dry humor, but also real respect for how hard lab interpretation can be. The hosts do not pretend this is simple. They do not pretend every case resolves right away. Instead, they talk through the uncertainty and explain why the right answer often takes time. That makes the episode more useful than a quick take would be. As the discussion narrows, the hosts reassure that the patient is not in immediate danger. That matters because abnormal labs can feel urgent even when the short-term risk is low. The message is to stay calm while still looking for the cause. The episode balances that reassurance with the reminder that something is still going on. It is not a dismissal. It is a disciplined pause. Dr. Austin Baraki helps move the reasoning forward. The dialogue uses questions as pivots, not decoration. Each new answer trims the differential without pretending to close the case too soon. That structure gives the episode its rhythm. It also makes the clinical logic easier to follow for listeners who live around these questions every day. The closing notes turn the case back toward practice. Lab interpretation is hard. Even experienced clinicians can get pulled into the wrong lane. The hosts argue for guidance, consultation, and a slower read on abnormal results when the story does not fit the numbers. The final advice is blunt in a useful way. Do not try to do this alone. This is a show that treats a common lab anomaly as a chance to correct a blind spot. It assumes the listener can handle physiology, differential diagnosis, and some skepticism about easy answers. It also assumes that the best medical move is often to ask one more good question before naming the disease. That assumption gives the episode its value.

As heard by us

A careful reminder not to mistake gym damage for liver disease.

An episode about a young asymptomatic man with elevated liver-associated enzymes uses the case to show how exercise-induced muscle damage can look like liver disease.

Read the full review in PlayNext →

Why you'd press play

When your labs look worse than you feel, this episode helps you think before you panic.

Read the full recommendation in PlayNext →
Listen to the show on